Retatrutide — lab test, July 2026
COA KVR-2026-DD88B4 matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
QHV40X7Test results
About this test
Label 60 mg · Lab measured 61.81 mg
103% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 15.5 mg using the measured mass, against 15 mg on the label — 3% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-DD88B4 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 24 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Kovera Labs on July 11, 2026. Reported purity: 99.629%. Net content: 61.81 mg against 60 mg labeled (103% of label). Endotoxins: Pass (≤0.5 EU/mL); Fentanyl Presence Analysis: Not Detected. Heavy metals: Arsenic, Cadmium, Lead, Mercury — all Negative. Batch RT60-0705. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion